Ocular Hypertension, Glaucoma research hub

A Therapeutic Non-Inferiority, Randomized, Observer-blind, Active-comparator, Two-arm, Parallel Group, Multi-center Clinical Trial for Comparing the Efficacy and Tolerability of a Generic Fixed Dose Combination of Brimonidine Tartrate 2 mg/ml + Timolol 5 mg/ml Eye Drops versus Combigan® 2 mg/ml + 5 mg/ml Eye Drops in the Treatment of Intraocular Pressure in Patients with Open Angle Glaucoma or Ocular Hypertension

This study compares two eye drop medications, Brimonidine-Timolol and Combigan, for treating eye conditions like glaucoma and ocular hypertension. Researchers want to see if the new generic eye drops work just as well as the established brand-name ones in lowering pressure inside the eye over 12 weeks, and if they cause similar side effects.